Grace Therapeutics Files 8-K
Ticker: GRCE · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1444192
| Field | Detail |
|---|---|
| Company | Grace Therapeutics, INC. (GRCE) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, financial-reporting
TL;DR
Grace Therapeutics (formerly Acasti Pharma) filed an 8-K on 3/3/25. Check it for corporate updates.
AI Summary
Grace Therapeutics, Inc. filed an 8-K on March 3, 2025, reporting on Other Events and Financial Statements and Exhibits. The company, formerly known as Acasti Pharma Inc. until August 28, 2008, is incorporated in Delaware and headquartered in Princeton, New Jersey.
Why It Matters
This filing provides an update on Grace Therapeutics' corporate events and financial reporting, which is crucial for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Numbers
- 001-35776 — SEC File Number (Identifies the company's filing with the SEC.)
- 0001444192 — Central Index Key (Unique identifier for the company in the SEC EDGAR system.)
Key Players & Entities
- Grace Therapeutics, Inc. (company) — Registrant
- Acasti Pharma Inc. (company) — Former company name
- March 3, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Princeton, New Jersey (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What are the key financial statements or exhibits included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific contents are not detailed in the provided text.
When did Grace Therapeutics, Inc. change its name from Acasti Pharma Inc.?
The date of the name change from Acasti Pharma Inc. to Grace Therapeutics, Inc. was August 28, 2008.
What is the fiscal year end for Grace Therapeutics, Inc.?
The fiscal year end for Grace Therapeutics, Inc. is March 31.
What is the SIC code for Grace Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Grace Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Grace Therapeutics, Inc. (GRCE).